A curated and standardized adverse drug event resource to accelerate drug safety research

Citations Over TimeTop 1% of 2016 papers

Abstract

Identification of adverse drug reactions (ADRs) during the post-marketing phase is one of the most important goals of drug safety surveillance. Spontaneous reporting systems (SRS) data, which are the mainstay of traditional drug safety surveillance, are used for hypothesis generation and to validate the newer approaches. The publicly available US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) data requires substantial curation before they can be used appropriately, and applying different strategies for data cleaning and normalization can have material impact on analysis results. We provide a curated and standardized version of FAERS removing duplicate case records, applying standardized vocabularies with drug names mapped to RxNorm concepts and outcomes mapped to SNOMED-CT concepts, and pre-computed summary statistics about drug-outcome relationships for general consumption. This publicly available resource, along with the source code, will accelerate drug safety research by reducing the amount of time spent performing data management on the source FAERS reports, improving the quality of the underlying data, and enabling standardized analyses using common vocabularies.

Related Papers

• → Safety and Adverse Events following Non-invasive Electrical Brain Stimulation in Stroke: A Systematic Review(2022)8 cited
• → Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from Greece(2023)3 cited
• → Adverse event monitoring in clinical trials of felodipine and omeprazole(1992)3 cited
• → Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from Greece(2023)1 cited
• → People's Drug Guide to Deadly Drug Interactions Focuses on Drug/Drug, Drug/Food, and Drug/Vitamin Interactions(1998)